Nesiritide Trial "MR Evidence of Cardiac Inflammation Post-Stroke" Recruiting

On September 18, 2026, a clinical trial update was recorded for nesiritide under the study title "MR Evidence of Cardiac Inflammation Post-Stroke." The trial is registered as NCT05714618 and its current status is listed as recruiting. No phase information was provided for this study in the available data. Nesiritide remains classified as an unapproved research compound in this context. The update does not include any results, efficacy data, or safety findings. No outcome measures or interim data were reported alongside this status change. As the trial is still in the recruiting stage, no conclusions can be drawn about its eventual findings. Readers should note that recruiting status indicates the study is actively enrolling participants rather than reporting results. Further details, including the full study protocol and eligibility criteria, are available through the official clinical trial registry listing. This brief reflects only the recruiting status and title as recorded on the specified date. No additional claims about the compound's effects are made or implied by this update. For more background on nesiritide, readers can consult the compound overview.